| RS2106077292 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106077295 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106079710 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106080813 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106081379 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106081592 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106086566 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106088185 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106088642 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS2106089689 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106089798 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106094950 |
PAX3
|
Health Risk |
Pathogenic |
Craniofacial-deafness-hand syndrome, Craniofacial-deafness-hand syndrome |
| RS2106095025 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106095147 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106102271 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2106102324 |
ALS2
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis |
| RS2106102918 |
OBSL1
|
Health Risk |
Pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS2106103778 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2106107923 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106107966 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106108347 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106108500 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106108582 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106108885 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106108903 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106109048 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106109125 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2106109159 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106109435 |
CXCR2
|
Health Risk |
Pathogenic |
WHIM syndrome 2, WHIM syndrome 2 |
| RS2106109750 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106110019 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106110129 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106110358 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106110487 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106110712 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2106110871 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106111008 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106111411 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106111914 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106112637 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2106112761 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106113137 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106113312 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106114422 |
OBSL1
|
Health Risk |
Pathogenic |
— |
| RS2106116333 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, neonatal |
| RS2106116608 |
MRPL44
|
Health Risk |
Pathogenic |
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency, Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency |
| RS2106118762 |
OBSL1
|
Health Risk |
Pathogenic |
— |
| RS2106124828 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106126181 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106126478 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2106132144 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Benign familial hematuria |
| RS2106134408 |
BARD1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2106134415 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106134639 |
BARD1
|
Health Risk |
Pathogenic |
BARD1-related cancer predisposition, Familial cancer of breast |
| RS2106134966 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ovarian cancer |
| RS2106135008 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106135360 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106135562 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106135644 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2106145519 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2106145629 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106147306 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS2106147774 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106151184 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2106151229 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2106151385 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106151987 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106152005 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome 3b, autosomal recessive |
| RS2106152180 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS2106154439 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2106164384 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome 3b |
| RS2106164697 |
COL4A3
|
Health Risk |
Pathogenic |
Alport syndrome, Alport syndrome |
| RS2106164814 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Alport syndrome |
| RS2106170807 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106171232 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106171367 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2106171752 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106172051 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2106174926 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2106175500 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Alport syndrome 3b |
| RS2106183039 |
ECEL1
|
Health Risk |
Pathogenic |
— |
| RS2106185000 |
ECEL1
|
Health Risk |
Pathogenic |
— |
| RS2106196576 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106196612 |
CUL3
|
Health Risk |
Pathogenic |
CUL3-related disorder, CUL3-related disorder |
| RS2106196630 |
CUL3
|
Health Risk |
Likely pathogenic |
CUL3-related disorder, CUL3-related disorder |
| RS2106196885 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106196907 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106197058 |
DAW1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Ciliary dyskinesia |
| RS2106200388 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome |
| RS2106200406 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106201680 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS2106202524 |
CUL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without autism or seizures, Neurodevelopmental disorder with or without autism or seizures |
| RS2106202854 |
CUL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2106203654 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106203729 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106203794 |
PAX3
|
Health Risk |
Likely pathogenic |
— |
| RS2106203892 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106203978 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS2106204266 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS2106205676 |
CHRND
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 3B, Congenital myasthenic syndrome 3B |